12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe

NCT00525824 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1743

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Coronary Heart Disease
Atherosclerosis

Interventions

DRUG: Rosuvastatin (Crestor)
DRUG: Ezetimibe
DRUG: Simvastatin

Sponsor

AstraZeneca